Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | SMO | Q99835 | 1/20 | 0.32 |
| ▸ | BCDIN3D | Q7Z5W3 | 4/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4239340 | 0.75 | SMN1; SMN2 (0.31) | ALDH1A1TSHRPOLBMAPTSMN1; SMN2 | |
| SCHEMBL4240731 | 0.67 | PTGS1 (0.41) | ALDH1A1TSHRPOLBMAPTKDM4E | |
| SCHEMBL5359887 | 0.67 | TP53 (0.36) | ALDH1A1TSHRPOLBMAPTKDM4E | |
| SCHEMBL5361990 | 0.66 | CYP11B1 (0.37) | TSHRMAPTSMN1; SMN2 | |
| SCHEMBL8387760 | 0.63 | CYP11B1 (0.36) | ALDH1A1TSHRPOLBKDM4E | |
| SCHEMBL18113496 | 0.61 | RECQL (0.44) | ALDH1A1POLBMAPTSMN1; SMN2KDM4E | |
| SCHEMBL30554368 | 0.61 | RECQL (0.44) | ALDH1A1POLBMAPTSMN1; SMN2KDM4E | |
| SCHEMBL27639664 | 0.61 | CYP11B1 (0.35) | TSHRSMN1; SMN2 | |
| SCHEMBL5357964 | 0.61 | LMNA (0.35) | ALDH1A1POLBMAPT | |
| SCHEMBL285259 | 0.61 | CYP17A1 (0.35) | ALDH1A1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007145349-A2 | SUBSTITUTED PYRROLE DERIVATIVES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-12-21 | — | — | WO | disclosed |